Frontier IP Group steps up presence in Portugal through strategic partnership with the UK Department for International Trade

Frontier IP Chief Executive Officer Neil Crabb said: “We’re looking forward to building on our existing strong relationships with the British Embassy in Portugal and the Department of International Trade. The support and the connections they can provide will be invaluable in helping us grow our business in the country.”

Frontier IP Group (LON:FIPP), a specialist in commercialising university intellectual property have signed a partnership agreement with the UK government’s Department for International Trade, which paves the way for the Group to build on its growing position in Portugal.

The agreement will see the British Embassy in Lisbon provide strategic support to Frontier IP through regular meetings with the Ambassador and DIT staff, and introductions to potential industry partners and key decision makers in the Portuguese government and economy.

Frontier IP is already a leading university IP commercialisation partner in Portugal, home to a range of world leading companies, including those in the paper, cork and renewable energy sectors.

The Group has formal relationships with two of the country’s leading universities, the Universidade de Nova de Lisboa Faculty of Science and Technology (FCT Nova) and Universidade de Évora. The Group is in discussions with several other Portuguese universities and research institutes. Frontier will be announcing the first spin out shortly.

The Group staged its highly successful Capital Markets Day at the British Ambassador’s residence in Lisbon in January this year. More than 70 investors, government representatives and academics saw technology demonstrations, including medical devices and printable electronics based on cellulose technology.

The British Ambassador to Portugal Kirsty Hayes said: “We are very proud to witness Frontier IP’s growth in Portugal and the increasing number of projects they are working with and currently managing. Frontier IP plays a key role in stimulating a two-way flow of knowledge and brings a wealth of expertise into the commercialisation of IP, narrowing the gap between university research and successful commercial products. We now welcome Frontier IP as one of our Strategic Partners, which is also a recognition for DIT’s support to the company for the past two and a half years. It has been great to be part of this success, and we are committed to ensuring Frontier IP’s continued progress in the Portuguese market.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Frontier IP Group Plc

    More articles like this

    Frontier IP Group Plc

    Animal Lovers and Zoonotic Diseases: 5 Things to Know

    Zoonotic diseases, or zoonoses, are on the rise. That may first bring to mind exotic diseases like Ebola, but the reality is that many zoonotic infections happen closer to home, often during everyday activities. In 2018,

    Frontier IP Group Plc

    AI-based initiatives catalyzing immunotherapy in 2018

    Artificial intelligence (AI) has been dynamically changing the field of drug discovery in several areas, including immunotherapy, oncotherapy, neurological disease, and many more. Described here is an ensemble of the initiatives in place to advance the field of

    Frontier IP Group Plc

    Frontier IP Group Plc appoint N+1 Singer as sole broker

    Frontier IP Group PLC (LON:FIPP), a specialist in commercialising university intellectual property, today announced the appointment of Nplus1 Singer Advisory LLP as the Group’s sole broker with immediate effect. Allenby Capital Limited remains the Group’s Nominated Adviser.

    Frontier IP Group Plc

    Britain’s university spinout sector is thriving

    They are among Britain’s greatest national treasures and a powerful engine of ideas and innovation for the nation’s booming technology industry. But how good are UK universities at commercialising the research and expertise which springs from

    Frontier IP Group Plc

    Exscientia CEO explains how AI is transforming drug discovery

    In recent decades a strange confluence has formed in the pharmaceutical industry. A range of powerful technologies have brought enormous new capabilities to the sector, productivity has been simultaneously declining. Deloitte’s Centre for Health Solutions estimates that projected returns on investment

    Frontier IP Group Plc

    How technology is revolutionising the healthcare industry

    A technology revolution is transforming the healthcare industry, changing everything from how patients are diagnosed and treated to our battle against some of the world’s most serious diseases. It’s a revolution fuelled by new sources of

    Frontier IP Group Plc

    Artificial Intelligence will Revolutionise Drug Discovery

    New technologies are making their way into the healthcare industry and healthcare providers are already experimenting with advances such as smart pill technology, 3D-printed medication, and mobile apps. But probably the biggest potential lies in artificial intelligence

    Frontier IP Group Plc

    Rallybio forges joint venture with U.K. tech firm

    A Farmington biotech startup formed by a trio of former top Alexion executives said it is working on drug discovery with an artificial intelligence company in the United Kingdom. Rallybio, focused on rare diseases, has not yet publicly

    Frontier IP Group Plc

    What is leptospirosis and how can it harm us and our pets?

    Recently reported cases of the often fatal bacterial infection leptospirosis in dogs in Sydney have raised the issue of animal diseases that also affect humans. This zoonotic disease is spread by rats and other rodents. However, this

    Frontier IP Group Plc

    The Robot Uprising Is Here

    The robot uprising is inevitable. Take the world’s first raspberry-picking robot, an autonomous machine that’s in development by Fieldwork Robotics at the University of Plymouth in the UK. This fruit-picking Terminator, so to speak, was developed for

    Frontier IP Group Plc

    The UK’s 50 Most Disruptive Companies Revealed

    After receiving applications from a wide range of early stage and more established companies from across industries, the initial list was whittled down to 100 by D/SRUPTION. The list was then submitted to an expert judging

    Frontier IP Group Plc

    Artificial intelligence in the world of drug discovery

    Charlotte Walker-Osborn, a Partner and Head of Technology Sector (International) at global law-firm Eversheds Sutherland and a legal expert in technology law, explains some of the challenges and potential future of artificial intelligence (AI) in the

    Frontier IP Group Plc

    11 diseases which can cause infection

    Illnesses that can pass from animals to humans are known as zoonotic. They’re surprisingly common: More than six out of every 10 known infectious diseases in people are actually contracted from animals, according to the CDC.